Ad
Thursday, 2 November 2017
Former GSK boss to lead new UK accelerated drug access scheme
LONDON (Reuters) - Former GlaxoSmithKline boss Andrew Witty is to lead a new British scheme to accelerate access to ground-breaking medicines for conditions such as cancer, dementia and diabetes from April 2018, the government announced on Friday.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment